Effective PD-1 monoclonal antibody therapy despite low PD-L1 expression in hidradenocarcinoma: a retrospective review

Published: 4 September 2023| Version 1 | DOI: 10.17632/xm74h8f4rt.1
Contributors:
Jing Lin, Qian Li, Yanping Chen, Li Zhu, Zhiheng Ke, Huishan Zhang, Yufang Huang, Jianping Lu, Huazhen Xiao, Lu Si, Yu Chen

Description

The medical record of 83 patients diagnosed with hidradenocarcinoma from January 2012 to March 2022.The clinical data were collected from 3 centers.

Files

Categories

Clinical Data Collection

Funders

  • the Natural Science Foundation of Fujian Province
    Grant ID: 2023J011254
  • the Science Foundation for The Excellent Youth Scholars of Fujian Provincial Health Commission
    Grant ID: 2022ZQNZD009
  • Joint Funds for the Innovation of Science and Technology, Fujian Province
    Grant ID: 2021Y9227
  • Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy
    Grant ID: 2020Y2012

Licence